Features
March 2010 Issue
Small Device May Offer Big Boost To Heart Failure Survival
Implantable cardioverter-defibrillators are now routinely recommended for many heart failure patients.
After a heart attack or onset of cardiomyopathy, many people are left with a heart that pumps poorly. This is heart failure (HF), a condition primarily affecting people ages 65 to 85. HF increases the risk of dying suddenly from rapid, irregular, disorganized heart rhythms known as ventricular tachycardia (VT) and ventricular fibrillation (VF). About half of all HF patients die from cardiac arrest. But help is often available from implantable cardioverter-defibrillators (ICDs). These small devices act like internal shock paddles to save the lives of many patients with failing hearts.
To continue reading this entire article you must be a paid subscriber.
Subscribe to Heart Advisor
Heart Advisor is an informative monthly newsletter from Cleveland Clinic, the hospital rated #1 in cardiac care by U.S. News & World Report.
Already subscribe but haven't registered for all the benefits of the website? Click here.
Subscriber Log In
Forgot your password? Click Here.